Completed NA INTERVENTIONAL 4-arm NCT01967732

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

A Single-center, Open-label, Randomized, Controlled, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile and Safety of Tobacco Heating System 2.2 (THS 2.2) Following Single Use in Smoking, Healthy Subjects Compared to Conventional Cigarettes and Nicotine Nasal Spray.

Sponsor: Philip Morris Products S.A.

Conditions Smoking

Interventions CC NNS THS 2.2

Updated 6 times since 2017 Last updated: Mar 16, 2020 Started: Nov 30, 2013 Primary completion: Dec 31, 2013 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01967732, this NA trial focuses on Smoking and remains completed. Sponsored by Philip Morris Products S.A., it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Apr 2020 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philip Morris Products S.A.

Data source: Philip Morris Products S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belfast, United Kingdom